ESLT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Not a good buy right now: price is breaking down technically after a -4.90% regular-session drop and is sitting below/near key support (~684.9), while momentum (MACD) is still deteriorating.", "Wall Street price targets ($531\u2013$580) are well below the current ~$680 level, implying limited upside and meaningful downgrade/valuation risk at this price.", "Fundamentals are strong (2025/Q3 growth and margin expansion), but the current tape + positioning suggests better odds of near-term chop/down than an immediate rebound suited for an impatient entry."]
["Trend/Momentum: MACD histogram -9.309 and negatively expanding \u2192 bearish momentum is strengthening (downtrend pressure not yet exhausted).", "RSI(6) 36.864 \u2192 weak/near-oversold territory, which can allow a short bounce, but it is not a confirmed reversal signal on its own.", "Key levels: Pivot 709.633 (now overhead resistance). Support S1 684.891 (price ~680 is below/around this), next support S2 669.605.", "Interpretation: With price below pivot and pressing under S1, the path of least resistance remains down unless it quickly reclaims ~685\u2013710.", "Pattern-based projection: Similar candlestick setups imply modest positive drift (next day +1.62%, next week +3.22%), but that conflicts with the still-worsening MACD\u2014signals are mixed, not a clean \u2018buy now\u2019 setup.", "Intellectia Proprietary Trading Signals\n- AI Stock Picker: No signal on given stock today.\n- SwingMax: No signal on given stock today."]
can create conditions for a reflex bounce if selling pressure fades."]
or lower before any sustained rebound.", "Analyst targets are far below spot: recent published PTs ($531, $550, $
imply the stock is priced ahead of consensus valuation.", "Options flow is near-term bearish (put-heavy volume) alongside elevated IV, suggesting traders are paying up for protection.", "No fresh news catalyst this week to quickly change sentiment after a sharp down day."]
["Latest quarter: 2025/Q3.", "Revenue: $1.9216B, +11.88% YoY (healthy top-line growth).", "Net income: $133.4M, +68.63% YoY (strong operating leverage/profit acceleration).", "EPS: 2.8, +58.19% YoY (earnings momentum remains robust).", "Gross margin: 24.89%, +3.58% YoY (margin expansion supports quality of growth)."]
["Recent trend: Mixed-to-cautious. Two firms initiated/maintained Neutral/Equal Weight (JPMorgan Neutral; Morgan Stanley Equal Weight) citing much of growth priced in after a strong run; one firm stays bullish (BofA Buy) with slightly higher PT.", "Price targets: JPMorgan $580 (raised from $530), Morgan Stanley $531 (initiation), BofA $550 (raised from $540) \u2014 all below current ~$680, signaling Street sees the stock as ahead of fair value near term.", "Wall Street pros: Visible demand and defense spending tailwinds; demonstrated revenue growth and margin expansion.", "Wall Street cons: Valuation/expectations look stretched at current levels; defense outlook described as more nuanced; upside appears capped versus consensus PTs."]
